Matthew D. Breyer
- Molecular Biology top 0.5%
- Pharmacology top 0.05%
- Biochemistry top 0.02%
- Nephrology top 0.1%
- Endocrinology, Diabetes and Metabolism top 0.2%
- Co-authors
- Richard BreyerRaymond C. HarrisChuan‐Ming HaoYoufei GuanH R JacobsonLinda DavisZhonghua QiXiaoyan Zhang
- Topics
- Inflammatory mediators and NSAID effects (70 papers)Eicosanoids and Hypertension Pharmacology (47 papers)Ion Transport and Channel Regulation (45 papers)
- Cited by
- BiochemistryNephrologyPharmacology
- Partner nations
- United StatesChinaCanada
In The Last Decade
Matthew D. Breyer
203 papers receiving 15.7k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Molecular Biology 6.6k
- Pharmacology 4.3k
- Biochemistry 3.2k
- Nephrology 2.8k
- Endocrinology, Diabetes and Metabolism 2.8k
Countries citing papers authored by Matthew D. Breyer
This map shows the geographic impact of Matthew D. Breyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew D. Breyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew D. Breyer more than expected).
Fields of papers citing papers by Matthew D. Breyer
This network shows the impact of papers produced by Matthew D. Breyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew D. Breyer. The network helps show where Matthew D. Breyer may publish in the future.
Co-authorship network of co-authors of Matthew D. Breyer
This figure shows the co-authorship network connecting the top 25 collaborators of Matthew D. Breyer. A scholar is included among the top collaborators of Matthew D. Breyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew D. Breyer. Matthew D. Breyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 8 | |
| 3 | 7 | |
| 4 | 39 | |
| 5 | 213 | |
| 6 | 8 | |
| 7 | 275 | |
| 8 | 16 | |
| 9 | 40 | |
| 10 | 21 | |
| 11 | 89 | |
| 12 | 12 | |
| 13 | 75 | |
| 14 | 50 | |
| 15 | 77 | |
| 16 | 115 | |
| 17 | 13 | |
| 18 | 176 | |
| 19 | 131 | |
| 20 | 122 |
About Matthew D. Breyer
Matthew D. Breyer is a scholar working on Biochemistry, Nephrology and Pharmacology, having authored 204 papers that have together received 16.0k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (70 papers), Eicosanoids and Hypertension Pharmacology (47 papers) and Ion Transport and Channel Regulation (45 papers). The work is most often cited by research in Biochemistry (3.2k citations), Nephrology (2.8k citations) and Pharmacology (4.3k citations). Matthew D. Breyer has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Richard Breyer, Raymond C. Harris, Chuan‐Ming Hao, Youfei Guan, H R Jacobson, Linda Davis, Zhonghua Qi, Xiaoyan Zhang, Reyadh Redha and Scott A. Myers. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.